Australian Specialized REITs Stock News

Half year earnings shift Insignia Financial into profit Insignia Financial (ASX:IFL) has put fresh numbers on the table, with half year earnings to December 31, 2025 showing A$830 million in sales and net income of A$78.8 million after a net loss a year earlier. See our latest analysis for Insignia Financial. At a share price of A$4.66, Insignia Financial has seen a 2.87% 90 day share price return and a 6.39% 1 year total shareholder return. This suggests momentum has been steady rather than...

Fresh from its H1 2026 report, Bellevue Gold (ASX:BGL) posted trailing twelve month revenue of A$441.4 million and a basic EPS loss of A$0.04, with net income excluding extra items at a loss of A$55.3 million. The company has seen revenue move from A$249.3 million in H2 2024 to A$222.3 million in H1 2025 and A$172.6 million in H2 2025, while basic EPS shifted from A$0.06 in H2 2024 to A$0.01 in H1 2025 before slipping to a loss of A$0.04 in H2 2025. For investors, that combination of a solid...

Symal Group (ASX:SYL) has put fresh numbers on the board for H1 2026, with trailing twelve month revenue of A$988.2 million and net income of A$48.2 million, against a current share price of A$2.50. The company has seen revenue move from A$391.1 million in H2 2024 to A$403.6 million in H1 2025 and then A$485.0 million in H2 2025. Basic EPS stepped from A$0.048 in H1 2025 to A$0.123 in H2 2025, setting the scene for investors to weigh strong top line momentum against recent margin...

Greatland Resources (ASX:GGP) has just reported its H1 2026 numbers, with trailing 12 month revenue sitting at about A$1.9b and net income at around A$644m, while the current share price is A$13.83. Over recent periods the company has seen revenue move from A$0 in H2 2024 to about A$940.0m in H2 2025, alongside basic EPS shifting from a loss of A$0.071537 per share in H2 2024 to A$0.45805 per share in H2 2025. With a reported net profit margin of 33.6% and very strong recent earnings growth...

Why IPH (ASX:IPH) is back on investors’ radar IPH (ASX:IPH) has drawn fresh attention after its half year 2025 earnings update showed higher revenue and net income compared with the prior period, followed closely by a new on market share buyback announcement. See our latest analysis for IPH. IPH’s latest earnings and the fresh buyback plan have arrived after a choppy period, with a 7 day share price return of 7.9% following shorter term weakness, while the 1 year total shareholder return of...

Hearts and Minds Investments (ASX:HM1) has posted its H1 2026 numbers with trailing twelve month revenue of A$43.3 million and basic EPS of A$0.08, while the latest reported half year in H2 2025 showed revenue of A$28.1 million and basic EPS of A$0.06. This keeps the focus firmly on how much profit it is converting from its investment portfolio. Over recent reporting periods the company has seen revenue move from A$57.7 million in H2 2024 to A$133.6 million in H1 2025 and A$28.1 million in H2...

Austco Healthcare (ASX:AHC) has reported a solid set of H1 2026 numbers, with revenue of A$48.2 million and net income of A$4.7 million translating to basic EPS of A$0.0128 as the company updates the market on its latest half year. Over the past three reported halves, revenue has moved from A$36.9 million in H1 2025 to A$44.5 million in H2 2025 and now A$48.2 million, while basic EPS has shifted from A$0.0081 to A$0.0082 and now A$0.0128. Together, these figures give investors clearer...

When companies post strong earnings, the stock generally performs well, just like Viva Leisure Limited's ( ASX:VVA...

As the Australian market navigates a busy reporting season, bolstered by gains in tech stocks and fluctuating commodity prices, investors are keenly watching the ASX for signs of stability and growth. In this environment, identifying stocks with strong fundamentals becomes crucial, as they offer resilience amid economic shifts and sector-specific developments.

nib holdings has recently announced adjustments to its 2026 health insurance premiums across Australian Residents Health Insurance and other segments, reflecting updated regulatory and market conditions. Because premiums are a core revenue lever, these changes may influence nib’s balance between growth, affordability, and claims cost control across its portfolio. We’ll now examine how these 2026 premium adjustments may affect nib holdings’ investment narrative, particularly around revenue...

XRF Scientific (ASX:XRF) has just put fresh numbers on the table, with H1 2026 results sitting against a backdrop where revenue in H2 2025 was A$30.7 million and basic EPS was A$0.038, alongside trailing twelve month revenue of A$59.4 million and EPS of A$0.074. Over the past few halves the company has seen revenue move from A$31.5 million in H2 2024 to A$28.7 million in H1 2025 and A$30.7 million in H2 2025, while basic EPS has ranged from A$0.0319 to A$0.038. This sets up a story where...

Earlier in February 2026, Santana Minerals Limited announced firm commitments for an A$130,000,000 follow-on equity offering at A$0.90 per share, issuing more than 144 million new ordinary shares at a small discount to fund its Bendigo Ophir Gold Project and broader exploration work. A key backdrop to this capital raise is the company’s recently declared extensional Exploration Target at the Rise & Shine deposit, which outlines additional potential mineralisation supported by step-out...

As the Australian market navigates a busy reporting day with major companies revealing their financial results, there's an optimistic outlook buoyed by positive movements in global markets. The term 'penny stocks' might seem outdated, but these smaller or newer companies still offer intriguing opportunities for investors seeking value and growth potential. By focusing on those with solid financials and clear growth trajectories, penny stocks can present hidden opportunities worth exploring.

Some Bravura Solutions Limited ( ASX:BVS ) shareholders may be a little concerned to see that the Non-Executive...

Toubani Resources Limited ( ASX:TRE ) is possibly approaching a major achievement in its business, so we would like to...

Some Evolution Mining Limited ( ASX:EVN ) shareholders may be a little concerned to see that the Non-Executive...

Netwealth Group (ASX:NWL) has just reported its H1 2026 results, with H2 2025 revenue at A$169.0 million and basic EPS of A$0.24, alongside trailing 12 month revenue of A$362.8 million and EPS of A$0.23. The company has seen revenue move from A$131.9 million and EPS of A$0.18 in H2 2024 to A$155.4 million and EPS of A$0.24 in H1 2025, then to A$169.0 million and EPS of A$0.24 in H2 2025. These developments set the stage for investors to weigh the latest numbers against a backdrop of softer...

Australian Clinical Labs (ASX:ACL) is in focus after reporting half year 2025 results that show lower net income while sales remained close to prior levels, and the company also declared a fully franked interim dividend. See our latest analysis for Australian Clinical Labs. The latest half year result and interim dividend have arrived against a weaker backdrop for shareholders, with the share price at A$2.15 after a 30 day share price return decline of 15.35% and a 1 year total shareholder...

Botanix Pharmaceuticals (ASX:BOT) has drawn fresh attention after filing multiple follow on equity offerings totaling A$45 million. The company is issuing new ordinary shares at A$0.06 with attached options that could reshape its capital structure. See our latest analysis for Botanix Pharmaceuticals. That equity raising lands after a sharp reset in sentiment, with a 1 day share price return showing a 41.33% decline at the latest A$0.066 close and a 1 year total shareholder return of 86.80%...

Australian shares are on the rise, bolstered by a strong February reporting season and modest gains on Wall Street, contributing to an optimistic outlook for investors. For those willing to explore beyond the well-known blue-chip stocks, penny stocks—often representing smaller or newer companies—offer intriguing possibilities. While the term may seem outdated, these stocks continue to present opportunities for growth at lower price points when supported by solid financials and fundamentals.

Zip Co (ASX:ZIP) has launched a new brand platform called "In You We Trust". The company has rolled out a national "You Trust Me?" campaign to support the new positioning. Alongside the branding shift, Zip Co is introducing product updates and new app features focused on trust and flexibility. Zip Co operates in digital financial services, where competition from both traditional banks and newer fintechs has been intense. By centering its new platform on trust and customer control, ASX:ZIP...

We'd be surprised if QEM Limited ( ASX:QEM ) shareholders haven't noticed that an insider, Gavin Loyden, recently sold...

In the last week, the Australian market has remained flat, but over the past 12 months, it has seen a modest rise of 3.6%, with earnings forecasted to grow by 12% annually. In this environment, selecting dividend stocks with solid yields can be an effective strategy for investors seeking steady income and potential growth in their portfolios.

As Australian shares gear up for a modest open amid the bustling February reporting season, investors are keeping a close watch on the Reserve Bank of Australia's latest policy meeting minutes. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that can offer unique investment opportunities. By focusing on those with solid financial foundations and growth potential, investors might uncover hidden gems in the market.